Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Biopharma Cred. (BPCR) Share Price

Price $0.908 on 19-12-2025 at 19:30:04
Change $0.002 0.22%
Buy $0.91
Sell $0.904
Last Trade: Buy 418,044.00 at $0.908
Day's Volume: 585,539
Last Close: $0.908
Open: $0.904
ISIN: GB00BDGKMY29
Day's Range $0.904 - $0.91
52wk Range: $0.80 - $0.94
Market Capitalisation: $1.03b
VWAP: $0.908033
Shares in Issue: 1.13b

Biopharma Cred. (BPCR) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 418,044 $0.908 Suspected BUY Trade
16:35:04 - 19-Dec-25
Sell* 223 $0.904 SI Trade
16:29:57 - 19-Dec-25
Sell* 326 $0.904 SI Trade
16:29:57 - 19-Dec-25
Sell* 274 $0.906 SI Trade
16:29:56 - 19-Dec-25
Sell* 4,250 $0.90704 Ordinary
16:15:06 - 19-Dec-25
Sell* 45 $0.906 SI Trade
16:06:17 - 19-Dec-25
Sell* 228 $0.906 SI Trade
16:06:17 - 19-Dec-25
Unknown* 8,403 $0.908 Negotiated Trade
16:02:22 - 19-Dec-25
Unknown* 978 $0.908724 Currency Conversion
Negotiated Trade
16:01:23 - 19-Dec-25
Unknown* 7,425 $0.908 Negotiated Trade
15:59:16 - 19-Dec-25
See more Biopharma Cred. trades

Biopharma Cred. (BPCR) Share Price History

Time period:
to
Date Open High Low Close Volume
19th Dec 2025 (Fri) 0.904 0.91 0.904 0.908 585,539
18th Dec 2025 (Thu) 0.90 0.91 0.90 0.906 1,786,374
17th Dec 2025 (Wed) 0.902 0.91 0.90 0.91 749,292
16th Dec 2025 (Tue) 0.90 0.91 0.896 0.898 1,013,495
15th Dec 2025 (Mon) 0.902 0.908 0.90 0.90 454,383
12th Dec 2025 (Fri) 0.912 0.912 0.90 0.90 873,932
11th Dec 2025 (Thu) 0.906 0.91 0.90 0.91 583,971
10th Dec 2025 (Wed) 0.904 0.912 0.904 0.91 691,877
9th Dec 2025 (Tue) 0.91 0.914 0.902 0.902 960,627
8th Dec 2025 (Mon) 0.906 0.914 0.906 0.914 648,290
5th Dec 2025 (Fri) 0.91 0.918 0.91 0.91 726,437
4th Dec 2025 (Thu) 0.91 0.918 0.906 0.918 567,265
3rd Dec 2025 (Wed) 0.91 0.918 0.902 0.908 1,020,598
2nd Dec 2025 (Tue) 0.90 0.91 0.90 0.91 832,427
1st Dec 2025 (Mon) 0.90 0.906 0.892 0.90 573,983
28th Nov 2025 (Fri) 0.90 0.90 0.894 0.90 1,095,342
27th Nov 2025 (Thu) 0.892 0.898 0.876 0.894 1,482,082
26th Nov 2025 (Wed) 0.89 0.896 0.884 0.894 4,667,353
25th Nov 2025 (Tue) 0.896 0.896 0.886 0.888 951,545
24th Nov 2025 (Mon) 0.892 0.896 0.884 0.886 2,226,731
21st Nov 2025 (Fri) 0.89 0.894 0.884 0.886 1,393,530
See more Biopharma Cred. price history

Biopharma Cred. (BPCR) Regulatory News

Date Source Headline
19th Dec 2025 4:00 pm RNS Net Asset Value(s) and Monthly Factsheet
21st Nov 2025 4:00 pm RNS Net Asset Value(s) and Monthly Factsheet
4th Nov 2025 3:29 pm RNS Director/PDMR Shareholding
24th Oct 2025 4:00 pm RNS Net Asset Value(s) and Monthly Factsheet
21st Oct 2025 7:00 am RNS UPDATES ON INVESTMENT PORTFOLIO
7th Oct 2025 7:00 am RNS NEW INVESTMENT OF US$30 MILLION
23rd Sep 2025 4:00 pm RNS Net Asset Value(s) and Monthly Factsheet
22nd Sep 2025 7:00 am RNS Half-year Report
18th Sep 2025 5:15 pm RNS Dividend Declaration
3rd Sep 2025 12:21 pm RNS NEW INVESTMENT OF UP TO US$62.5 MILLION
See more Biopharma Cred. regulatory news

Biopharma Cred. (BPCR) Share News

UK dividends calendar - next 7 days

24th Oct 2025 11:25

Read More

IN BRIEF: Biopharma Credit increases loan commitment to Valneva

7th Oct 2025 11:22

BioPharma Credit PLC - London-based closed-ended investment company focused on life sciences industry - Provides a senior secured loan to Valneva Austria GmbH, a subsidiary of Valneva SE. Initial tranche is expected to be funded in the coming weeks, with BioPharma investing USD30 million and BioPharma Credit Investments V (Master) LP investing an additional USD185 million in parallel, and BioPharma acting as collateral agent. "Further tranches of up to USD285 million for potential business development are subject to mutual agreement by the parties with loan allocations to be determined at such time," BioPharma adds. The loan to Valneva will mature in October 2030 and bear an interest of 9.00% per year. Read More

BioPharma Credit expects pipeline growth as net asset value ticks up

22nd Sep 2025 09:37

(Alliance News) - BioPharma Credit PLC on Monday said net asset value increased, while the net income for the first half of the year substantially covered its annual dividend target. Read More

UK earnings, trading statements calendar - next 7 days

15th Sep 2025 15:29

Read More

Burberry, recently debuted Metlen Energy & Metals to join FTSE 100

3rd Sep 2025 19:40

(Alliance News) - Burberry Group PLC and Metlen Energy & Metals PLC have been promoted to the FTSE 100 in its latest quarterly shuffle, with Taylor Wimpey PLC and Unite Group PLC relegated from the benchmark index. Read More

See more Biopharma Cred. news
FTSE 100 Latest
Value9,897.42
Change59.65

Login to your account

Forgot Password?

Not Registered